Peter D. Siersema

Active 1992–2025

235
Papers
32,442
Citations
106
h-index
228
i10-index

Citations

Citations per year for Peter D. Siersema1985: 1 citations1993: 4 citations1994: 2 citations1995: 1 citations1997: 3 citations1998: 2 citations1999: 6 citations2000: 7 citations2001: 15 citations2002: 14 citations2003: 11 citations2004: 20 citations2005: 33 citations2006: 46 citations2007: 58 citations2008: 45 citations2009: 115 citations2010: 77 citations2011: 141 citations2012: 165 citations2013: 254 citations2014: 252 citations2015: 279 citations2016: 288 citations2017: 376 citations2018: 352 citations2019: 1,069 citations2020: 1,258 citations2021: 1,171 citations2022: 892 citations2023: 649 citations2024: 1,034 citations2025: 479 citations2026: 13 citations1986–1992: no citations, so these years are not shown1996: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,676 citing papers, 18.5% of this breakdownChina: 1,319 citing papers, 9.1% of this breakdownNetherlands: 1,218 citing papers, 8.4% of this breakdownUnited Kingdom: 1,015 citing papers, 7% of this breakdownItaly: 867 citing papers, 6% of this breakdownGermany: 810 citing papers, 5.6% of this breakdownJapan: 533 citing papers, 3.7% of this breakdownFrance: 527 citing papers, 3.6% of this breakdownSpain: 446 citing papers, 3.1% of this breakdownCanada: 432 citing papers, 3% of this breakdownAustralia: 324 citing papers, 2.2% of this breakdownBelgium: 283 citing papers, 1.9% of this breakdown
0%18.5%Other 27.9%

Fields

  • Medicine68.9%
  • Biochemistry, Genetics and Molecular Biology20.3%
  • Engineering3.4%
  • Immunology and Microbiology1.8%
  • Nursing1.1%
  • Dentistry0.9%
  • Other3.6%

Topics

  • Esophageal Cancer Research and Treatment4.8%
  • Esophageal and GI Pathology4.3%
  • Cancer Cells and Metastasis4.1%
  • Gastric Cancer Management and Outcomes3.9%
  • Inflammatory Bowel Disease3.5%
  • Colorectal Cancer Screening and Detection3.3%
  • Other76.1%

Coauthors

All papers

Open in search
  1. Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium

    Authors: , , , , , , , , , , - Gastroenterology 2011 cited by 3,790

  2. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

    Authors: , , , , , , , , , , , , , , - Gut 2011 cited by 851

  3. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline – Updated October 2017

    Authors: , , , , , , , , , , , , , , - Endoscopy 2018 cited by 764

  4. Declining Risk of Colorectal Cancer in Inflammatory Bowel Disease

    Authors: , , , , , - Inflammatory Bowel Diseases 2013 cited by 515

  5. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Miren Dorronsoro, J. Ramón Quirós, Eric J. Duell, Weimin Ye, Malin Sund, Björn Lindkvist, Dorthe Johansen, Kay‐Tee Khaw, Nick Wareham, Ruth C. Travis, Paolo Vineis, H. Bas Bueno‐de‐Mesquita, Elio Ríboli - Gut 2012 cited by 411

  6. Textbook outcome as a composite measure in oesophagogastric cancer surgery

    Authors: , , , , , , , , , , , , , , , , , , , , , , - British journal of surgery 2017 cited by 296

  7. Reducing the environmental footprint of gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) Position Statement

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cesare Hassan, Ian M. Gralnek, Helmut Messmann - Endoscopy 2022 cited by 197

  8. Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement

    Authors: , , , , , , , , , , , , , , , , , - Endoscopy 2020 cited by 174

  9. Combined impact of healthy lifestyle factors on colorectal cancer: a large European cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alessio Naccarati, Salvatore Panico, Peter D. Siersema, Petra H. Peeters, Ingrid Ljuslinder, Ingegerd Johansson, Ulrika Ericson, Bodil Ohlsson, Elisabete Weiderpass, Guri Skeie, Kristin Benjaminsen Borch, Sabina Rinaldi, Isabelle Romieu, Joyce Kong, Marc J. Gunter, Heather Ward, Elio Ríboli, Heiner Boeing - BMC Medicine 2014 cited by 260

  10. Volatile organic compounds in breath can serve as a non‐invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer

    Authors: , , , , - Alimentary Pharmacology & Therapeutics 2019 cited by 140

  11. 18F-Fludeoxyglucose–Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hanneke W.M. van Laarhoven, Kevin P. Wevers, Lieke Hol, Frank J. Wessels, Nadia Haj Mohammad, Miriam P. van der Meulen, Geert Frederix, Erik Vegt, Peter D. Siersema, Jelle P. Ruurda, PLASTIC Study Group, Jessy Joy van Kleef, Mariska J Prins, Joyce Pijpers, Jerôme Profar, Stan Tummers, Kees de Mooij, Maaike van Dam, Monique Heijmans, Antoinette van Groenestyn, Edith Bouwmeester, Ilse Masselink, Damiana Beumer, Nel de Vries - JAMA Surgery 2021 cited by 81

  12. Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , G. J. A. Offerhaus, Frank P. Vleggaar, Wouter L. Curvers, Geert‐Jan Creemers, Mark J. Roef, Maurice J.C. van der Sangen, Jeroen Buijsen, Robert G. Riedl, Wendy Schreurs, Fabienne Warmerdam, MJR Janssen, Chella van der Post, Sandra A. Radema, Camiel Rosman, Heidi Rütten - The Lancet Oncology 2018 cited by 332

  13. Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine

    Authors: , , , , , , , , , - Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2011 cited by 186

  14. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial

    Authors: , , , , , , , - Gastrointestinal Endoscopy 2009 cited by 558

  15. High lifetime risk of cancer in primary sclerosing cholangitis

    Authors: , , , , - Journal of Hepatology 2008 cited by 416

  16. Coffee Drinking and Mortality in 10 European Countries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ­Rosario ­Tumino, Bas Bueno‐de‐Mesquita, Peter D. Siersema, Max Leenders, Joline W. J. Beulens, Cuno U. Uiterwaal, Peter Wallström, Lena Nilsson, Rikard Landberg, Elisabete Weiderpass, Guri Skeie, Tonje Braaten, Paul Brennan, Idlir Licaj, David C. Muller, Rashmi Sinha, Nick Wareham, Elio Ríboli - Annals of Internal Medicine 2017 cited by 223

  17. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study

    Authors: , , , , , , , , , , , , , , , , , , , , , - Gut 2012 cited by 498

  18. Dairy Products, Dietary Calcium, and Risk of Inflammatory Bowel Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Hart, Bas Oldenburg - Inflammatory Bowel Diseases 2016 cited by 97

  19. Local recurrence after endoscopic mucosal resection of nonpedunculated colorectal lesions: systematic review and meta-analysis

    Authors: , , , - Endoscopy 2014 cited by 397

  20. Barrett oesophagus

    Authors: , , , , , , , , , , - Nature Reviews Disease Primers 2019 cited by 161

  21. Dietary intake of patients with inflammatory bowel disease: A comparison with individuals from a general population and associations with relapse

    Authors: , , , , , - Clinical Nutrition 2018 cited by 105

  22. Gastric Outlet Obstruction: Current Status and Future Directions

    Authors: , - Gut and Liver 2022 cited by 56

  23. Staging investigations for oesophageal cancer: a meta-analysis

    Authors: , , , , - British Journal of Cancer 2008 cited by 511

  24. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2021

    Authors: , , , , , , , , , , , , , , , , - Endoscopy 2021 cited by 156